Horizon 2020
The EU Framework Programme for Research and Innovation

Developing tools for early diagnosis and treatment of Alzheimer's

PANA has set out to develop an innovative method to diagnose Alzheimer's in its early stages, up to five years before the occurrence of clinical symptoms. This could increase the duration and quality of patients' lives considerably.
image of elderly hands holding blurred photographs

Alzheimer’s disease is the leading cause of dementia and loss of autonomy among elderly people today, posing a huge challenge for families, medical professionals and society in general.

There is currently no effective method for early diagnosis of Alzheimer’s, which effectively limits the use of early therapeutic strategies to delay onset of the disease’s most adverse symptoms.

Read more

Project information

Name: 
PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.
Acronym: 
PANA
Article
#H2020